Hemato-Oncology and Bone Marrow Transplantation (BMT): Diagnostic procedures ranging from the basic to the most sophisticated including Cytogenetics, Fluorescence in Situ Hybridization (FISH), Flow Cytometry and DNA analysis by PCR techniques.
Autologous BMT, allogeneic BMT, allogeneic BMT from an unrelated donor, mismatched allogeneic BMT and Mismatched Haploidentical BMT .

The Department of Hematology serves as a referral center for patients with a variety of blood disorders and is a center for Intensive Hemato-Oncology and Stem Cell Transplantation.

The department includes a large outpatient clinic with several sub-specialties, day-care facilities, a clinical ward and Blood and Marrow Transplantation (BMT) unit, and laboratories.

A multidisciplinary team of hematologists, transplant specialists, nurses, infectious disease specialists, dieticians, psychologists, social workers and pharmacists, provide the highest quality clinical care for patients with diverse benign and malignant blood-related diseases. Clinical disorders of particular focus include acute and chronic leukemias, MDS, malignant lymphomas, Hodgkin's Disease and Multiple Myeloma.

Treatment options include:

- The latest chemotherapy regimens for newly diagnosed
   patients.
- Salvage and experimental chemotherapies for patients
   with relapsed disease.
- Monoclonal antibodies for the treatment of lymphomas
  and leukemias.
- New, targeted therapies for patients with CML, multiple
  myeloma and lymphoma.

The BMT program offers:
- Autologous peripheral blood stem-cell transplantation.
- Allogeneic transplants for a matched family member or
  unrelated donors.
- National and international donor search.
- New transplantation approaches utilizing reduced
  intensity regimens and "mini" transplants.
- Cellular immunotherapies employing donor immune cells
  for relapsed or residual disease.
- The department's laboratories, radiation therapy and
  transfusion medicine services provide comprehensive
  support for these treatments.